Evidence map›Paper›PMID 41281615›Full record

ArticleBlood neoplasia2025

Luspatercept treatment affects immune-regulatory subsets in patients with MDS with ring sideroblasts.

Stefania Leone, Francesco Grimaldi, Mara Memoli, Giulia Scalia, Annamaria Vincenzi, Maria Di Perna, Giuseppe Cerciello, Antonio Vassallo, Fabrizio Pane, Alessandra Picardi and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood neoplasia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Stefania LeoneHematopoietic Stem Cell Transplantation Unit, Azienda Ospedaliera A. Cardarelli, Naples, Italy.
Francesco GrimaldiDivision of Hematology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Mara MemoliDivision of Hematology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Giulia ScaliaClinical and Experimental Cytometry Unit, Centre for Advanced Biotechnology Franco Salvatore, CEINGE Biotecnologie Avanzate, Naples, Italy.
Annamaria VincenziDivision of Hematology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Maria Di PernaHematology, Hospital "Andrea Tortora," Pagani, Italy.
Giuseppe CercielloDivision of Hematology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Antonio VassalloDepartment of Health Sciences, University of Basilicata, Potenza, Italy.
Fabrizio PaneDivision of Hematology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Alessandra PicardiHematopoietic Stem Cell Transplantation Unit, Azienda Ospedaliera A. Cardarelli, Naples, Italy.
Giuseppe TerrazzanoDepartment of Health Sciences, University of Basilicata, Potenza, Italy.
Giuseppina RuggieroDepartment of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
Flavia CarrieroDepartment of Health Sciences, University of Basilicata, Potenza, Italy.
Valentina RubinoDepartment of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41281615
PMCPMC12630101

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.